TCG Crossover Management, LLC
Q2 2025 13F Holdings
- Locationpalo alto, CA
- Num holdings
38
- Value ($000)
$875,508
- Date Filed08/14/2025
- Form type13F-HR
- CIK0001839948
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
CGON CG ONCOLOGY INC | COMM | 156944100 | $95.43 M | 11 % | 3,670,206 | ||
TNGX TANGO THERAPEUTICS INC | COMM | 87583X109 | $54.97 M | 6 % | 10,736,000 | ||
COGT COGENT BIOSCIENCES INC | COMM | 19240Q201 | $50.00 M | 6 % | 6,964,375 | ||
OCUL OCULAR THERAPEUTIX INC | COMM | 67576A100 | $49.36 M | 6 % | 5,319,148 | ||
CDTX CIDARA THERAPEUTICS INC | COMM | 171757206 | $49.00 M | 6 % | 1,005,901 | ||
ABIVAX SA AMERICAN DEPOSITARY SHARES | ADRS | 00370M103 | $46.33 M | 5 % | 6,056,596 | ||
AMLX AMYLYX PHARMACEUTICALS INC | COMM | 03237H101 | $38.10 M | 4 % | 5,943,812 | ||
CNTA CENTESSA PHARMACEUTICALS PLC | ADRS | 152309100 | $37.99 M | 4 % | 2,890,816 | ||
FULC FULCRUM THERAPEUTICS INC | COMM | 359616109 | $36.12 M | 4 % | 5,250,000 | ||
DYN DYNE THERAPEUTICS INC | COMM | 26818M108 | $35.86 M | 4 % | 3,766,660 |
Rows Per Page
10
- 10
- 50
- 100